Valuation: Treace Medical Concepts, Inc.

Market Cap 278M 244M 225M 208M 394M 26.59B 402M 2.7B 1.05B 13.01B 1.04B 1.02B 45.16B P/E 2026 *
-4.75x
P/E 2027 * -5.12x
Enterprise Value 323M 283M 261M 241M 458M 30.9B 467M 3.14B 1.22B 15.12B 1.21B 1.19B 52.49B EV / Sales 2026 *
1.56x
EV / Sales 2027 * 1.65x
Free-Float
74.37%
Yield 2026 *
-
Yield 2027 * -
1 day-1.29%
1 week+1.18%
Current month+7.54%
1 month+21.25%
3 months+205.71%
6 months+44.59%
Current year+74.69%
1 week 4.13
Extreme 4.1317
4.7
1 month 3.73
Extreme 3.73
4.78
Current year 1.17
Extreme 1.17
4.78
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
25.22
5 years 1.17
Extreme 1.17
31.76
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Compliance Officer 50 2022-09-30
Director TitleAgeSince
Director/Board Member 68 2020-11-19
Chairman 80 2014-06-30
Director/Board Member 64 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
06-10Buy

Chief Executive Officer

9,891 0.0152%
06-09Other

Chief Executive Officer

0 0%
05-31Buy

Chief Executive Officer

50,000 0.0771%
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%+1.18%-30.52%-81.59% 278M
-0.21%+0.27%+28.04%-3.08% 12.48B
-0.03%-2.88%+60.38%+35.00% 5.99B
+0.60%-1.71%+4.63%+11.06% 5.6B
+0.87%-1.12% - - 4.22B
+2.03%-0.80%-34.73%+6.18% 3.92B
-1.12%-1.46%-26.38%-27.56% 3.77B
+2.59%+10.08%-0.80%-57.72% 2.01B
-1.09%+0.95%+15.61%+253.89% 1.87B
+2.00%+2.79%+57.98%-3.32% 1.53B
Average +0.42%+1.61%+8.24%+14.76% 4.17B
Weighted average by Cap. +0.33%+0.21%+16.29%+12.96%

Financials

2026 *2027 *
Net sales 206M 181M 167M 154M 293M 19.75B 298M 2.01B 780M 9.67B 775M 758M 33.55B 222M 195M 180M 166M 315M 21.24B 321M 2.16B 839M 10.39B 833M 815M 36.08B
Net income -58.31M -51.14M -47.21M -43.63M -82.7M -5.58B -84.35M -568M -221M -2.73B -219M -214M -9.48B -54.66M -47.94M -44.26M -40.9M -77.52M -5.23B -79.08M -532M -207M -2.56B -205M -201M -8.89B
Net Debt 45.05M 39.52M 36.48M 33.71M 63.9M 4.31B 65.18M 439M 170M 2.11B 169M 165M 7.33B 88.04M 77.22M 71.29M 65.88M 125M 8.43B 127M 857M 333M 4.13B 331M 323M 14.32B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-07-08 US$4.280 -2.95% 480,749
26-07-07 US$4.410 -3.29% 624,865
26-07-06 US$4.560 +8.31% 662,392
26-07-02 US$4.210 -0.47% 460,661
26-07-01 US$4.230 +6.28% 493,356
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.280USD
Average target price
4.000USD
Spread / Average Target
-6.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock